2004
DOI: 10.1016/j.jcf.2004.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Altered terminal glycosylation and the pathophysiology of CF lung disease

Abstract: Altered terminal glycosylation, with increased fucosylation and decreased sialylation, is a hallmark of the cystic fibrosis (CF) glycosylation phenotype. The glycosylation phenotype of CF airway epithelial cells has been modulated by the expression of wtCFTR. Understanding the effects of mutant CFTR on glycosylation may provide further insight into the regulation of glycoconjugate processing as well as new approaches to the therapy of CF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
18
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 7 publications
0
18
0
Order By: Relevance
“…A female patient with cystic fibrosis showed high %CDT as well as a type 2 Tf-IEF profile, supporting the hypothesis that altered function of cystic fibrosis transmembrane conductance regulator (CFTR) affects the compartmentalization of glycosyltransferases in the Golgi, thereby disturbing protein glycosylation (39 ). Moreover, we have found several types of Tf polymorphisms that hampered efforts to reach a conclusive diagnosis in sick children.…”
Section: Discussionmentioning
confidence: 52%
“…A female patient with cystic fibrosis showed high %CDT as well as a type 2 Tf-IEF profile, supporting the hypothesis that altered function of cystic fibrosis transmembrane conductance regulator (CFTR) affects the compartmentalization of glycosyltransferases in the Golgi, thereby disturbing protein glycosylation (39 ). Moreover, we have found several types of Tf polymorphisms that hampered efforts to reach a conclusive diagnosis in sick children.…”
Section: Discussionmentioning
confidence: 52%
“…CFTR itself is a highly glycosylated protein, and there are published data that suggest that the sugar composition of membrane glycoproteins and secreted mucins is altered in CF, though the exact mechanism remains unknown (45). We are currently testing whether N-glycosylation or HSPGs are upregulated in lung tissues from patients with CF.…”
Section: Discussionmentioning
confidence: 99%
“…In studies of Stable Isotope Labeling with Amino acids in Cell culture (SILAC) for profiling of pancreatic cancer cell secretomes, 145 differentially expressed proteins infrequently correlate with mRNA analysis [49,103]. Moreover, function(s) of proteins will depend on post-translational modifications [26,102,112]. Microarrays are also limited as they only detect known sequences included within any given array and the actual detection system may be limited by either falling below the level of detection or by presenting a saturating signal [130].…”
Section: Genomics and Proteomics: A Means To De-termine Fingerprints mentioning
confidence: 99%